A detailed history of Larson Financial Group LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Larson Financial Group LLC holds 21 shares of EXAS stock, worth $1,207. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21
Previous 15 40.0%
Holding current value
$1,207
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$42.43 - $70.83 $254 - $424
6 Added 40.0%
21 $1,000
Q2 2024

Aug 02, 2024

SELL
$41.33 - $74.26 $867 - $1,559
-21 Reduced 58.33%
15 $0
Q1 2024

May 03, 2024

BUY
$56.27 - $73.77 $1,969 - $2,581
35 Added 3500.0%
36 $2,000
Q4 2023

Feb 01, 2024

SELL
$59.06 - $75.72 $1,358 - $1,741
-23 Reduced 95.83%
1 $0
Q3 2023

Nov 03, 2023

SELL
$65.94 - $99.04 $12,660 - $19,015
-192 Reduced 88.89%
24 $1,000
Q2 2023

Aug 03, 2023

BUY
$62.68 - $95.05 $13,538 - $20,530
216 New
216 $20,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.